AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 NOV 7 - (NewsRx.com & NewsRx.net) -- Cryo-Cell International, Inc., (CCEL) announced the company's preliminary fiscal third quarter sales for its umbilical cord blood (U-Cord) preservation program.
John V. Hargiss, president and CEO, commented, "The company has set new revenue records for both quarterly and monthly performance. When comparing year-to-date revenue derived solely from the cord blood processing business, the company posted a 57% increase over the comparable prior year's period. August 2002 represents a significant increase over August of last year. Most importantly, August culminated eight consecutive months of sales increases, the last five of which were sequential record setting ...
Source: HighBeam Research, Record 3Q 2002 sales reported from cord blood program.(Cryo-Cell...